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SUMMARY

The stem cells that maintain and repair the postnatal
skeleton remain undefined. One model suggests that
perisinusoidal mesenchymal stem cells (MSCs) give
rise to osteoblasts, chondrocytes, marrow stromal
cells, and adipocytes, although the existence of
these cells has not been proven through fate-mapping experiments. We demonstrate here that expression of the bone morphogenetic protein (BMP)
antagonist gremlin 1 defines a population of osteochondroreticular (OCR) stem cells in the bone
marrow. OCR stem cells self-renew and generate
osteoblasts, chondrocytes, and reticular marrow
stromal cells, but not adipocytes. OCR stem cells

are concentrated within the metaphysis of long
bones not in the perisinusoidal space and are needed
for bone development, bone remodeling, and fracture repair. Grem1 expression also identifies intestinal reticular stem cells (iRSCs) that are cells of origin
for the periepithelial intestinal mesenchymal sheath.
Grem1 expression identifies distinct connective
tissue stem cells in both the bone (OCR stem cells)
and the intestine (iRSCs).
INTRODUCTION
Long bones consist of a cortex supported by an internal framework of trabecular bone. The trabecular bone and the adjacent
cartilaginous growth plates contain the cellular progenitors
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Figure 1. Grem1 Identifies Rare Adult Multipotent Mesenchymal Stromal Cells
(A) Protocol and (B) Grem1-creERT;R26-LSL-TdTomato;Nes-GFP mouse femur, showing that metaphyseal Nes-GFP+ (green) and Grem1+ cells (red, white
arrows) are distinct.
(C) Adult Grem1-creERT;R26-LSL-TdTomato bone marrow cells are rare and mesenchymal (CD45–CD31–Ter-119–).
(D–G) Adult Grem1-creERT;R26-LSL-TdTomato;Nes-GFP mice: Grem1 and mesenchymal Nes-GFP cells do not overlap, and clonogenicity is greater in the
Grem1+ versus the mesenchymal Nes-GFP+ cells (CD45–CD31–Ter-119–). (E and F) 10 cm cell culture dish; (G) n = 5, data shown with mean ± SD, p = 0.013.

(legend continued on next page)
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necessary for postnatal bone growth. The prevailing model for
the development, growth, and repair of long bones proposes
two phases. First, cartilage cells lay down a matrix that forms a
‘‘scaffold’’ for bone formation. Osteoblasts then invade this matrix and lay down the mineralized parts of bone (Kronenberg,
2003). Although this process—termed ‘‘endochondral ossification’’—has been known for decades, it remains unclear whether
postnatal bones are grown and repaired by osteoblasts and
chondrocytes already committed to their respective lineages,
or whether there are specialized multipotent cells that determine
postnatal growth and repair.
The mesenchymal stem cell (MSC) model suggests that a selfrenewing stem cell exists within the bone marrow that gives rise
to mature osteoblasts, chondrocytes, adipocytes, and marrow
stromal cells required for skeletal development, homeostasis,
and repair. A prime candidate for the endogenous MSC has
been the mesenchymal cells that surround the bone marrow
sinusoids (Bianco et al., 2013). Perisinusoidal mesenchymal cells
are marked by nestin (Nes)-GFP (Méndez-Ferrer et al., 2010) and
leptin receptor (Lepr)-cre (Ding et al., 2012; Mizoguchi et al.,
2014; Zhou et al., 2014) in mice and by CD146 in humans (Sacchetti et al., 2007).
Recently, perisinusoidal mesenchymal cells expressing Lepr
were found to include multipotent, colony-forming unit-fibroblasts (CFU-Fs) (Zhou et al., 2014). Lineage-tracing studies revealed that this perisinusoidal population also contained cells
with in vivo osteogenic and adipogenic potential; however, these
cells gave rise to osteo-adipogenic lineages exclusively in adult
animals (>8 weeks of age) and not during development or bone
growth (Ding et al., 2012; Mizoguchi et al., 2014; Zhou et al.,
2014). Furthermore, Lepr-expressing perisinusoidal cells never
contributed to normal developing chondrocytes, the major cell
lineage generating the cartilaginous matrix required for endochondral ossification (Ding et al., 2012; Mizoguchi et al., 2014;
Zhou et al., 2014). Thus, perisinusoidal MSCs do not fulfill all of
the characteristics expected of a skeletal MSC. In addition,
putative MSC markers such as Nes (Méndez-Ferrer et al.,
2010) have failed to prove that single MSCs have in vivo postnatal multipotentiality and self-renewal. Together, these data
raise the prospect that another complementary postnatal skeletal stem cell may exist.
We developed an inducible Cre transgenic line marking a
skeletal stem cell. In doing so, we discovered the osteochondroreticular (OCR) stem cell. We also provide evidence indicating that analogous connective tissue stem cells, intestinal
reticular stem cells (iRSCs), exist in the small intestine.
RESULTS
Generating a Specific Marker of Skeletal Stem Cells
To select a specific MSC marker in the bone and intestine, we
considered human gene-expression arrays from bone marrow,
intestine, and peritumoral mesenchyme (Delorme et al., 2009;

Kosinski et al., 2007; Sneddon et al., 2006). Gremlin 1 (Grem1),
identified from these studies, is a secreted antagonist of bone
morphogenetic protein (Bmp) -2, -4, and -7 and a VEGFR2
agonist (Hsu et al., 1998; Mitola et al., 2010). Grem1 is important
in normal skeletal and renal development and homeostasis
(Canalis et al., 2012; Khokha et al., 2003; Michos et al., 2004).
Furthermore, overexpression of Grem1 interrupts normal intestinal function and has been linked to intestinal cancer (Jaeger
et al., 2012).
We previously found that Grem1 expression identified the
most clonogenic fraction of marrow stromal cultures (Quante
et al., 2011). In the present study, we confirmed that expression
of Grem1 was increased in undifferentiated mesenchymal
cultures compared to endogenous bone marrow mesenchyme
(Figures S1A–S1C available online).
To extend these findings in vivo, we generated a tamoxifeninducible BAC transgenic creERT line specific for Grem1 expression (Grem1-creERT, Figures S1D–S1F, Table S1A). The
Grem1-creERT BAC transgenic line was crossed to different
reporters (such as R26-LSL-TdTomato and R26-LSL-ZsGreen)
and the R26-LSL-diphtheria toxin subunit A (DTA) line to allow
lineage tracing and functional ablation of specific mesenchymal
cells, respectively (See Tables S1B and S1C for summary of
transgenic lines).
Grem1+ Cells Are Distinct from, and More Clonogenic
than, Nes-GFP+ MSCs
Tamoxifen induction of adult Grem1-creERT;R26-LSL-TdTomato
mice (Figure 1A) resulted in recombination in and expression of
the TdTomato reporter (red fluorescent protein) in a rare and
exclusively mesenchymal population of bone marrow cells
(0.0025% of all single, live, nucleated cells after collagenase
digestion [95% confidence interval (CI) 0.0022–0.0028]). In this
experiment and elsewhere in the paper, we defined skeletal
mesenchyme as triple negative for CD45–Ter-119–CD31– in enzymatically digested bone and bone marrow cells. CD45 characterizes most hematopoietic cells with the exception of maturing
erythroid cells, which are marked by Ter-119. CD31 was used
to exclude endothelial cells (Park et al., 2012) (Table S1D). The
CD45-negative, Ter-119-negative, and CD31-negative fraction
of bone marrow defines the nonendothelial, nonhematopoietic
compartment that contains putative skeletal stem cells. Many
Grem1-creERT+ cells, identified by a recombined fluorescent
reporter gene shortly after tamoxifen administration (hereafter
referred to as Grem1+ cells), were immediately adjacent to the
growth plate and trabecular bone (Figures 1B, 1C, and 5B).
To determine the overlap between Grem1+ and other reported
CFU-F populations, we crossed Grem1-creERT to Nes-GFP;
R26-LSL-TdTomato (Grem1+ cells and their progeny were red,
and Nes-GFP-expressing cells were green) and to Acta2RFP;R26-LSL-ZsGreen (Grem1+ cells and their progeny were
green, and Acta2-RFP-expressing cells were red) (Grcevic
et al., 2012; Méndez-Ferrer et al., 2010). Adult Grem1+ cells

(H–K) Grem1+ cells from Grem1-creERT;R26-LSL-ZsGreen;Acta2-RFP mice could be clonally expanded in vitro and differentiated into bone (H) (alizarin red),
cartilage (I) (toluidine blue), and myofibroblasts (J) (Grem1+ green-derived cells with coexpression of Acta2 [red]), but very limited adipogenesis (oil red) (K). Lower
right insets show equivalent stain in a control marrow culture.
In all graphs, the data are shown with the mean ± SD.

Cell 160, 269–284, January 15, 2015 ª2015 Elsevier Inc. 271

A

B

C

D

E

F

G

H

J

K

I

L

Figure 2. Grem1+ Cells Are Enriched for CD105 Bone Marrow Cells with Upregulated Osteochondral versus Adipogenic Gene Expression
(A–F) n = 3, Grem1+ cells from adult, collagenase-digested whole bone and bone marrow were compared to the Grem1-negative population. On average, 40%
(95% CI 20%–60%) of all Grem1 cells were CD45–CD31–Ter-119–CD105+ compared to only 1.8% of Grem1-negative cells (F, p = 0.014). (C) Grem1+ cells,
however, were not further enriched for other MSC markers CD140a and Sca-1. Grem1+ and Grem1-negative cells were compared across the increasingly
specific immunophenotypes; data shown with mean ± SD.

(legend continued on next page)
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did not express Nes-GFP (Figures 1B and 1D), and only a minority of Grem1+ cells expressed Acta2-RFP (mean 5.9% of Grem1+
were Acta2+; Figure S2A). The Grem1+ population was more clonogenic than Nes-GFP or Acta2-RFP cells, even after depletion
of contaminating nonmesenchymal lineages (Figures 1D–1G
and S2B). Grem1+ CFU-Fs did not initially express Acta2-RFP,
but during culture, the Grem1+ progeny differentiated into
Acta2-RFP-expressing myofibroblasts (these cells were
yellow, expressing both ZsGreen and Acta2-RFP; Figure S2C).
Importantly, the proportion of CFU-Fs was diminished within
the Grem1+ descendants expressing Acta2-RFP, suggesting
that Acta2 expression marks a more differentiated cell less
capable of clonogenic growth (Figure S2D). Grem1+ cells, however, never gave rise to Nes-GFP-expressing cells, either in
adherent culture or in vivo (10 months tracing after adult tamoxifen induction of Grem1-creERT;R26-LSL-TdTomato;Nes-GFP
mice; Figure S2E).
For the clonal differentiation experiments (Figure 1), adult
Grem1-creERT;R26-LSL-ZsGreen;Acta2-RFP and Grem1creERT;R26-LSL-TdTomato mice were administered tamoxifen
by oral gavage at 6–8 weeks of age. Bones were processed as
described (see Experimental Procedures), and the fluorescent
Grem1+ cells were sorted by fluorescence-activated cell sorting
(FACS) and plated at clonal density < 2,500 cells/10 cm dish.
Clones (i.e., isolated clusters of > 50 cells at 10–14 days) were
harvested using a cloning cylinder and expanded into individual
wells for differentiation. We evaluated 19 clones after in vitro differentiation. Single clones gave rise to osteoblasts (defined by
alizarin red [Figure 1H] or alkaline phosphatase staining in 84%
of clones, [Figures S2F and S2G]), chondrocytes (100% of clones
confirmed by toluidine blue staining), and myofibroblasts on
the basis of coexpression of the Acta2-RFP transgene (100%,
Figures 1H–1J). In contrast, the Grem1+ cell-derived clones
showed little capacity for adipocytic differentiation (defined by
oil red staining, Figure 1K, 0 of 19 single clones). Polyclonal cultures from sorted Grem1+ cells also failed to differentiate into
adipocytes.
A substantial proportion (40%) of Grem1+ cells, in addition
to being triple negative for CD45–Ter-119–CD31–, were also
positive for CD105, a well-established marker of bone marrow
CFU-Fs (Park et al., 2012). In contrast, less than 2% of
the Grem1-negative cells were CD45–CD31–Ter-119–CD105+.
Grem1+ cells, however, expressed lower levels of CD140a and
Sca-1 (Figures 2A–2F). The Grem1+ population was enriched
for CD45–CD31–Ter-119–CD105+ cells, a subpopulation previously reported to contain all mouse bone marrow CFU-Fs
(Park et al., 2012). It followed that Grem1+ cells were also enriched for CFU-Fs compared to Grem1-negative fractions
(Data S1A and S1B). It is worth noting that we used standard
adherent cell culture conditions (aMEM with 10% FBS), whereas
other studies have used 20% FBS, hypoxic conditions, and a

ROCK inhibitor, which enhance the recovery of CFU-Fs (Zhou
et al., 2014). Thus, the exact CFU-F efficiencies reported in our
study may not be directly comparable to other reports.
Gene-expression microarray of Grem1+ versus Grem1-negative mesenchymal (CD45–CD31–Ter-119–) cells revealed 1,426
differentially expressed genes (false discovery rate [FDR] <
0.05). The Grem1+ population had significantly higher expression
of many osteoblast (Sp7), chondrocyte (Acan), pericytic (Cpsg4,
Fap), and putative stem cell genes (Klf4), all of which were
confirmed by qPCR (Figures 2G–2M, Table S1E, and Data S1C
and S1E). Grem1+ cells did not differentially express Nes (Figure 2H) or other genes typical of the perisinusoidal mesenchymal
niche (Table S1E).
To determine the signaling pathways that were activated in the
Grem1+ cells, we investigated candidate pathways previously
reported to be relevant in MSC differentiation, such as the
BMP, TGF-b, FGF/PDGF, and VEGF pathways (Gerber et al.,
1999; Ng et al., 2008). Although all of these pathways were statistically significant (<2.2 3 1016 by the c2 test), only the genes in the
Bmp-activating pathway were consistently increased. Bmp2,
Bmp5, Bmp6, the Bmp receptor Acvr1, and the BMP signaling
target gene Id2 were all upregulated in Grem1+ versus Grem1negative mesenchymal cells (Data S1F and Table S1F). To support the role of BMP signaling in the Grem1+ population, we
performed qPCR on 23 clones derived from Grem1+ bone
marrow cells. Id2 was expressed in 100% of clones, and Bmp2
was expressed in 91% of clones. Furthermore, using flow cytometry, pSmad1,5, a marker of BMP signaling, was detected in
37.5% of Grem1+ versus 5.8% of Grem1-negative freshly sorted
cells (Data S1G, p = 0.004). In contrast, genes identified in the
TGF-b, FGF/PDGF, and VEGF pathways were found to be both
activators and repressors and so did not generate a coherent
signal constituting pathway activation (Data S1F, S1H, and S1I).
We also used an unbiased analysis in which all differentially
expressed genes in Grem1+ versus Grem1-negative cells (fdr <
0.05) were evaluated against the KEGG and Reactome databases. Pathways with a gamma fdr < 0.05 are included in Table
S1G (KEGG) and Table S1H (Reactome). The top 3 significant
KEGG pathways, the ECM-receptor interaction, PI3K-Akt
signaling, and focal adhesion pathways, were all activated
according to PathwayGuide’s statistical criterion. Differentially
expressed genes from these pathways are given in Tables S1I–
S1K. Many of the genes upregulated in these pathways are
involved in differentiation into bone and cartilage and include
the following: chondroadherin, cartilage oligomeric matrix protein, fibroblast growth factors, collagens, integrins, and cyclins.
Taken together, BMP signaling along with ECM-receptor interaction, PI3K-Akt signaling, and focal adhesion pathways were
all significantly activated in the Grem1+ cells and are likely to
be important either in determining or as a consequence of the
Grem1+ cells’ osteochondral lineage potential.

(G) Microarray was performed to compare the Grem1+ (red) to the nonrecombined stromal (CD45–CD31–Ter-119–) population (green); in qPCR, we also sorted
and evaluated the CD45CD31Ter-119+ population (blue) that did not contain any recombined cells.
(H) Grem1+ cells were not enriched for Nes expression.
(I–L) qPCR confirmation of microarray revealed that Grem1+ cells had increased expression of pericytic (Cpsg4; I) and osteochondral genes (Acan and Sp7; J and
K) but no association with the adipogenic differentiation gene Pparg (L).
In all graphs, the data are shown with the mean ± SD.
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The expression profile of Grem1+ cells was enriched for
genes implicated in bone and cartilage, rather than adipocytic,
differentiation (Data S1J; Tables S1L–S1N). Furthermore,
Grem1+ cells, and their derivative clones, expressed active inhibitors of adipogenesis (e.g., Nr2f2; Data S1K; Xu et al., 2008).
The exact molecular explanation for the more restricted mesenchymal repertoire of Grem1+ cells, however, remains to be
confirmed.
Further qPCR analysis of 23 Grem1+ cell-derived clones
confirmed the mesenchymal homogeneity of Grem1 cells and
their derivative clones (Data S1L). Interestingly, 100% of the
Grem1+ clones expressed both Nes and Grem1, and Grem1
transcripts were also detectable within polyclonal Nes-GFP cultures. Thus, endogenous Grem1 and Nes expression are not as
mutually exclusive as their respective transgenes in vivo. Finally,
GREM1 is also expressed in human MSCs. We examined three
distinct human MSC lines derived from normal bone marrow,
normal synovium, or inflamed synovium. All lines expressed
GREM1 (Data S1M).
Grem1 Cells Are Endogenous OCR Stem Cells
Grem1-creERT;R26-LSL-ZsGreen;Acta2-RFP mice were induced with perinatal tamoxifen (postnatal day [P] 1, Figure 3A).
In these mice, all Grem1+ cells and their subsequent progeny
were labeled by green fluorescence, and any cells expressing
Acta2 were marked by red fluorescence. Twenty-four hours after
P1 induction, Grem1+ (green) cells were present within the primitive mesenchyme and the primary spongiosa of the femur. In
contrast, the Acta2-expressing (red) stromal cells were localized
within the bone marrow (Figure 3B). By P5, Grem1+ cells had
differentiated into columns of chondrocytes (Figures 3C and
3D, green) as well as spindle-shaped stromal cells immediately
inferior to the developing growth plate (Figures 3C and 3E).
By using Grem1-creERT;R26-LSL-TdTomato;2.3colGFP mice,
one can track Grem1+ cells and their progeny by red fluorescence, and osteoblasts are marked by green fluorescence. The
2.3colGFP mouse is a transgenic line in which GFP expression,
driven by a short 2.3 kb promoter element from the rat collagen
1a1 gene, has been used to identify committed osteoblasts
(Kalajzic et al., 2002). After 6 weeks, the P1-labeled Grem1+ cells
had differentiated into reticular marrow stromal cells (red), chondrocytes (red), and osteoblasts (yellow), all concentrated within
the peritrabecular bone area (Figures 3F–3I). Many of the reticular
marrow stromal cells anatomically spanned perivascular and
endosteal regions and were CD105+ by immunostaining (Figure S3A). As early as 4 weeks (P28) following P1 induction,

Grem1+ cells give rise to approximately 64% of the bone and
50% of the chondrocytes within the metaphysis and epiphysis,
albeit with little contribution to diaphyseal bone (Figure S3B).
To prove that the fluorescent cells represented clonal populations, we generated Grem1-creERT;R26-Confetti mice and
again induced at P1. Single-color clones of chondrocytes and
marrow stromal cells were present by 6 weeks, confirming single-cell multipotentiality (Figures 3J and 3K). Our Monte Carlo
simulation confirmed that the majority (>90%) of patches of
adjacent identically colored cells (‘‘clones’’) were likely to be
monoclonal in origin (see Experimental Procedures).
Approximately 12 months after adult (6–8 weeks, Figure 3L)
tamoxifen induction of Grem1-creERT;R26-LSL-TdTomato
mice (and Grem1-creERT;R26-LSL-ZsGreen, mice), we found
that Grem1+ cells had differentiated into columns of chondrocytes (Figures 3M and 3N), articular cartilage (Figure S3C), reticular marrow stromal cells (Figure 3O), periosteal cells (Figure 3P),
diaphyseal osteoblasts (Figure S3D), and osteocytes (Figure 3P).
No adipocytes, either in the femurs (Figure S3E) or in the vertebral bodies (Figure S3F), were derived from adult Grem1+ cells,
even at 1 year after tamoxifen induction. Fluorescently labeled
Grem1+ cells harvested from the bone marrow after 1 year could
still self-renew in vitro. The harvested Grem1+ cells in culture
formed large colonies, which were clonally expanded (using
cloning cylinders) to prove that they retained clonal in vitro multipotentiality, even 12 months after adult tamoxifen induction
(Figure S3G). Again, in vitro differentiation was skewed to osteoblast and chondrocyte (Figures S3G–S3J), with little in vitro adipogenesis (Figure S3H). These results indicate that expression
of Grem1 also identified adult multipotent stem cells.
To confirm that Grem1+ cells were functional, postnatal skeletal
stem cells, we generated Grem1-creERT;R26-LSL-ZsGreen;R26LSL-DTA mice and Grem1-creERT;R26-LSL-ZsGreen littermate
and related controls. In these mice, Cre-mediated excision of a
STOP signal leads to the expression of the Diphtheria toxin
(DTA) and thus ablation of Grem1-expressing cells. We administered four daily doses of 2 mg subcutaneous tamoxifen starting
at P9 and measured total body and left femoral bone volume
by microcomputed tomography (CT) at P23 (Quantum FX
Micro-CT, Perkin-Elmer; Figures S4A–S4C). Grem1 cells were
incompletely ablated, although reduced, as assessed by the
proportion of ZsGreen-expressing cells in the bone marrow
(Figure S4A). The DTA+ mice were significantly smaller than the
controls (Figure S4B). There was a significant difference in femoral
volume between the groups and a trend toward reduced total
bone volume in the DTA versus the control mice (Figure S4C).

Figure 3. Endogenous Grem1 Cells Self-Renew and Lineage Trace Bone, Cartilage, and Stroma
(A) Protocol.
(B–E) P1 induction in Grem1-creERT;R26-LSL-ZsGreen;Acta2-RFP mice. (B) At 24 hr after tamoxifen, Grem1 recombined (green) only within the primary
spongiosa of long bones distinct from the Acta2-RFP (red) cells in the marrow. But, over the following 96 hr (C), the Grem1 cells began organizing into chondrocytic columns (D) and differentiated into stromal cells that invade the bone marrow (E) intertwined with Acta2-positive (red) cells.
(F–I) Grem1-creERT;R26-LSL-TdTomato;2.3colGFP mice induced at P1, examined at 6 weeks, show that the Grem1+ cells generate reticular marrow stromal
cells (G), chondrocytes in the epiphyseal plate (H), osteoblasts (2.3colGFP+, thus yellow) in the trabecular bone (I).
(J) Grem1-creERT;R26-Confetti P1 induction, examined at 6 weeks, revealed clonal populations of chondrocytes, and (K) serial sections confirm mixed clones,
yellow clone shown, of chondrocytes and marrow stromal cells, low- and higher-power (inset) images.
(L–P) Adult induction in Grem1-creERT;R26-LSL-TdTomato analyzed 11 months after adult induction (L). Grem1+ cells had generated chondrocytes (M and N),
reticular marrow stromal cells (O), and bone and periosteal cells (red) (P).
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Figure 4. Nes-GFP Cells Make Little Contribution to Skeletal Tissues during Early Life
(A) Whole-mount in situ hybridization on mouse embryos at E9.5, E10.5, E11.5 and E12.5. These embryos were evaluated for Sox9, Runx2, Grem1, and Nes
expression. Nes-creERT; R26-LSL-TdTomato; Nes-GFP mice (n = 3) were generated to lineage trace from Nes-GFP-positive cells throughout the bone marrow.
These mice were induced at P1 and examined 6–8 weeks after.
(B) Protocol.

(legend continued on next page)
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We noted that the major site of Grem1-driven recombination at
P23, after P9 induction, was within the femoral epiphysis (nearly
60% of the epiphyseal bone was labeled). Therefore, we examined anatomically comparable sections in Grem1 DTA versus
control mice and measured the fraction of mineralized bone in
the femoral epiphysis. Here too, the trabecular bone fraction
was significantly reduced in DTA mice versus control mice
(Figure S4D). This suggested a functional role of Grem1+ cells
in postnatal skeletogenesis. We acknowledge, however, that
ablation of extra-skeletal Grem1+ cells may have indirectly
contributed, at least in part, to the impaired skeletogenesis.
We measured the expression of Grem1, Nes, Runx2, and Sox9
by whole-mount in situ hybridization during the earliest stages of
hindlimb bud development, i.e., embryonic day (E) 9.5, E10.5,
E11.5, and E12.5 (Figure 4A). Grem1 was expressed at the onset
of hindlimb development, E9.5. Nes was not expressed within
the hindlimb at these stages. To confirm that Grem1 marked
a multipotent mesenchymal stem/progenitor cell during development, we administered tamoxifen to pregnant Grem1creERT;R26-LSL-TdTomato dams at E13.5. Consistent with
the in situ hybridization findings, Grem1 was expressed within
much of the primitive hindlimb mesenchyme within the embryos
and gave rise to almost all of the cells within the primitive mesenchyme and the primary spongiosa by E21 (Figures S4E and S4F).
Taken together, these results confirm that Grem1 expression
marked a new, endogenous skeletal stem cell, in development
and adulthood, which lacked any significant capacity for adipogenesis. As a result, it does not meet the minimal criteria for
MSCs (Dominici et al., 2006). Thus, we named these Grem1+
stem cells as osteochondroreticular ‘‘OCR stem cells’’ in reference to the earlier concept of the osteochondroprogenitor
(Ducy et al., 1997).
Perisinusoidal Nes-GFP+ Cells May Not Be Skeletal Stem
Cells during Early Life
The previously published Nes-cre and Nes-creERT lines may
not reliably identify the perisinusoidal Nes-GFP cells that are
purported to be endogenous MSCs (Ding et al., 2012; MéndezFerrer et al., 2010). Thus, we used a different transgenic Nes-creERT line in an attempt to better understand the lineage potential of Nes-GFP+ perisinusoidal MSCs (Dranovsky et al.,
2011). Compared to previously reported Nes reporter mouse
lines, the transgenic Nes-creERT line used here had a different
Nes regulatory sequence directing the expression of creERT
(Dranovsky et al., 2011). Following P1 tamoxifen induction of
Nes-creERT;R26-LSL-TdTomato;Nes-GFP mice (Figure 4B),
Nes-creERT recombined R26-LSL-TdTomato in approximately
4% of all bone marrow Nes-GFP cells by 6–8 weeks (Figure 4C).
This included metaphyseal (Figure 4D), periarteriolar (Figure 4E),
and perisinusoidal Nes-GFP cells (Figures 4F–4H). In keeping
with previous perisinusoidal lineage-tracing studies, this Nes-creERT line did not generate cartilage or trabecular bone by
6–8 weeks (Ding et al., 2012; Mizoguchi et al., 2014). The only os-

teochondral cells that were traced consisted of rare, isolated osteocytes embedded within the diaphyseal cortical bone (Figure 4H). Our findings suggest that perisinusoidal cells, labeled
by Nes-GFP, may not be the principal skeletal stem cells during
development or early postnatal life (Ding et al., 2012; Mizoguchi
et al., 2014; Zhou et al., 2014). It is quite possible, however, that
the endogenous Nes gene or other Nes-transgenic lines could be
expressed in postnatal skeletal stem/progenitor cells, but that
these cells were not captured by our lineage-tracing strategy in
young (<8-week-old) mice.
Grem1+ OCR Stem Cells Contribute to Fracture Repair
Do adult Grem1 OCR stem cells respond to skeletal injury? Adult
Grem1+ cells do not overlap with 2.3colGFP+ osteoblasts.
Grem1+ cells are, however, adjacent to osteoblasts in vivo and
during early adherent bone marrow stromal culture (Figures 5B
and 5C). Surgical fracture with internal fixation of the femur in
Grem1-creERT;R26-LSL-TdTomato;2.3colGFP mice (performed
1 week after adult induction with tamoxifen) (Figures 5A and 5D)
resulted in Grem1+ OCR stem cell expansion and differentiation
into 2.3colGFP-positive (and osteocalcin-positive, Figure S5D)
osteoblasts and 2.3colGFP-negative, Sox9+ chondrocytes
within the fracture callus (Figures 5E–5H and S5A–S5C). The
Grem1+ OCR stem cell lineage, as defined by red fluorescence,
contributed approximately 28% of osteoblasts (red and
2.3colGFP green) and 14% of chondrocytes (defined by Sox9
immunostaining and/or by hematoxylin and eosin staining
[H&E] on serial sections) within the fracture callus.
Next, we tested whether Grem1+ cells could be transplanted
into the fracture site. We harvested and expanded a clonal
population of Grem1+ OCR stem cells. This clone, mixed with
hydrogel, was applied to the fracture site at the time of injury
and engrafted into the callus of the recipient wild-type mice
(Figures 5I and 5J). The transplanted cells differentiated into
osteoblasts (alkaline phosphatase-expressing) within the fracture callus (Figure 5K). OCR stem cells self-renewed within the
callus and were recovered from the recipient animals and rapidly
expanded again in fracture callus cultures (Figure 5L). The
Grem1+ OCR stem cells cultured from the fracture callus and
expanded in vitro could be serially transplanted into a second
fracture (Figure S5E). Thus, Grem1 expression identifies developmental and adult, both physiological and reactive, endogenous OCR stem cells amenable to serial transplantation.
Grem1 Expression also Defines a New iRSC
Could Grem1 also mark extramedullary connective tissue stem
cells? The small intestine was selected as our extramedullary
organ of interest because the gut is known to contain multipotent
mesenchymal stromal cells (Powell et al., 2011). It is worth
emphasizing that we searched for a connective tissue stem
cell within the lamina propria and not for an epithelial stem cell,
such as that previously identified by Lgr5 expression (Barker
et al., 2007). Furthermore, the small intestine does not contain

(C) By flow cytometry, approximately 4% of Nes-GFP-positive cells recombined (that is, were both green and red).
(D–H) This specific Nes-CreERT transgenic line recombined in all typical Nes-GFP populations, including perivascular cells immediately inferior to the growth
plate (D), in periarteriolar cells (E), and in perisinusoidal Nes-GFP-positive cells (red arrows, F–H). The only osteochondral lineage tracing found were isolated
osteocytes throughout the diaphyseal bone (H, white arrow).
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Figure 5. Adult Grem1 Cells, Both Endogenous and Transplanted, Differentiate into Osteochondral Fracture Callus
(A) Protocol.
(B and C) Grem1-creERT;R26-LSL-TdTomato;2.3colGFP mice adult induction: Grem1+ (red) cells were not osteoblasts (green) but were adjacent to each other
in situ (B) and during the first week of adherent bone marrow stromal culture (C).
(D) is an X-ray of the femoral osteotomy and internal fixation of the bone.
(E) and (F) show the serial histology and fluorescent microscopy sections from the resulting fracture callus after the osteotomy.
(G) and (H) are magnified from areas shown in (F). Grem1+ cells (red) stream into the fracture site and differentiate into either osteoblasts (G, yellow cells, white
arrows) or Sox9+ (white, nuclear stain) chondrocytes (yellow arrows) (H).
(I) A Grem1+ clone, after adult induction, was expanded in vitro. An osteotomy with internal fixation was performed in wild-type mice, at which point 500 3 106
clonal cells (red) were irrigated into the surgical field. Seven days later, the Grem1 clone had engrafted (J), the site of injury was identified by TdTomato fluorescence imaging, and recombined cells (fluorescent red) differentiated into osteoblastic cells (K) (alkaline phosphatase positive cells, red-brown, white arrows)
in the callus (sequential fluorescence microscopy and ALP staining performed on the same slide).
(L) Callus culture was performed, and the recombined Grem1 cells were easily recovered in vitro and serially transplanted into a secondary fracture (Figure S5E).
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bone and cartilage, and thus we were not expecting to find a
bona fide OCR stem cell. Rather, we were interested in testing
for an organ-relevant connective tissue stem cell, sharing
Grem1 expression and the defining stem cell characteristics
of self-renewal and multipotentiality. The connective tissue
immediately beneath the intestinal epithelium is a mesenchymal
sheath that invests the entire intestinal gland (Powell et al., 2011).
Adult Grem1 recombination (24 hr after 6 mg of tamoxifen by oral
gavage, Grem1-creERT;R26-mT/mG) identified single cells
(Grem1+ = green) immediately beneath the epithelium at the
junction between the small-intestinal crypt and villus, a region
known as the intestinal isthmus (Figures 6A and 6B). In situ hybridization confirmed Grem1 expression within periepithelial
isthmus cells, and these cells were also positive in the Grem1LacZ knockin line (Data S2A–S2F) (Khokha et al., 2003).
Single periepithelial Grem1 cells divided slowly (BrdU incorporation over 1 month of continuous dosing; Data S2G). Over time,
the fluorescently tagged Grem1+ cells gave rise to reticular, periepithelial mesenchymal lineages throughout both the crypt and
villus sheaths (Figures 6B–6E). The Grem1+ cells differentiated
into both Acta2-positive myofibroblasts (Figure 6F) and Acta2negative, but Ng2-positive, stromal cells (Data S2H). Grem1 cells
gave rise to an intricate reticular network of cells that invested
the entire gland (Figures 6B–6E, Movie S1). The Grem1 lineage
was distinct from the closely associated s100b (Data S2I)
and Nes-GFP positive periepithelial glial sheath (Data S2J)
(Belkind-Gerson et al., 2013). The Grem1+ cell lineage was intimately related to the overlying intestinal epithelium (Figures 6G
and Data S2K). After 6 to 9 months, intestinal Grem1 cells had
expanded to give rise to the mesenchymal sheath subjacent to
the Lgr5+ crypt base columnar stem cell zone (Figures 6B, 6C,
and 6E) (Barker et al., 2007). After 12 months, the cells had
also renewed the periepithelial mesenchymal sheath to the tip
of the villi (Figure 6B). The Grem1+ cells at the isthmus selfrenewed so that their fluorescently tagged lineage persisted
across the entire crypt-villus axis for at least 2 years after adult
tamoxifen induction (Data S2L). Perinatal induction at P1 led
to accelerated intestinal mesenchymal tracing (at 6 weeks),
providing further proof of the clonality of the Grem1 lineage
within the mesenchymal sheath (Grem1-creERT;R26-Confetti
mice; Data S2M). The Grem1 lineage also identified small-intestinal CFU-Fs (Data S2N). Similar patterns of lineage tracing were
evident throughout the entire gastrointestinal tract, including the
stomach (Data S2O). Grem1 also identified a progenitor population within the skin (Data S2O). The exact nature of these cells,
however, requires further study.
Extending the concept of connective tissue stem cells to extramedullary mesenchyme, however, requires that the model
be rigorously validated in vivo. We adapted a protocol for generating tissue-engineered small intestines (TESIs) to test whether
Grem1+ intestinal mesenchymal cells could be transplanted to
generate the small-intestinal, periepithelial mesenchymal sheath
within the recipient’s TESI graft (Levin et al., 2013). Grem1creERT;R26-LSL-TdTomato donor small-intestinal organoid
units were transplanted into the omentum of recipient wildtype mice. Only one or two Grem1+ cells were present within
the harvested donor units (Figure 6H), but they were able to
expand and restore the intestinal mesenchymal sheath in the

TESI (Figures 6I and Data S2P). Thus, small-intestinal Grem1+
cells self-renew and clonally generate multiple distinct, compartment-relevant mesenchymal lineages and can be transplanted
to recapitulate the periepithelial mesenchymal sheath, confirming that they are connective tissue stem cells. In this context,
we refer to them as iRSCs. We use this term, iRSCs, to reflect
their morphology and the reticular network formed by these cells
and in reference to their Grem1-expressing reticular counterparts in the bone marrow.
DISCUSSION
Despite intensive investigation, the identity of an endogenous
‘‘skeletal stem cell’’ has remained elusive. We generated an
inducible Cre line, driven by the enhancer elements of the BMP
antagonist Grem1, to identify and lineage trace rare skeletal
stem cells in vivo. Adult Grem1 OCR stem cells were found beside the growth plate and the trabecular bone, where they generated and maintained articular and growth plate cartilage, bone
and reticular marrow stromal cells, but not fat. Adult Grem1
OCR stem cells did not overlap with perisinusoidal Nes-GFP
MSCs, appear to be more clonogenic in vitro than Nes-GFP
MSCs, and make a far greater contribution to early postnatal
skeletogenesis than traditional perisinusoidal MSCs (Ding
et al., 2012; Zhou et al., 2014). This study complements the existing, perisinusoidal MSC model of postnatal skeletogenesis
(Figure 7) (Bianco et al., 2013). We have also identified Grem1expressing, reticular stem cells in the small intestine, the iRSCs,
that self-renew to maintain the multilineage periepithelial,
mesenchymal sheath. The iRSCs are distinct from, but analogous to, their Grem1-expressing OCR stem cells in the bone.
Each has an organ-appropriate mesenchymal repertoire, but
these Grem1-expressing stem cells are united by their capacity
for self-renewal, multipotentiality, and continued functionality
following transplantation.
Bone and cartilage could develop from a population of dedicated and committed postnatal progenitors (as with pancreatic
beta cells). Alternatively, they could arise from a multipotent
stem cell capable of generating bone, cartilage, and accessory
elements, such as adipocytes and pericytes. A third model,
which we favor, suggests that discrete stem cells make temporal
and lineage-specific contributions to skeletal development and
maintenance (Takashima et al., 2007). That is, the OCR stem
cell is a substantial skeletal stem cell in development and early
postnatal life, but over time, the perisinusoidal MSC increases
its contribution to skeletal homeostasis, such that ultimately
adult mesenchymal tissues are maintained from two separate,
but complementary, stem cell pools (Figure 7).
Perisinusoidal Nes-GFP MSCs fulfill the in vitro criteria of
MSCs (Méndez-Ferrer et al., 2010); however, they make little
endogenous contribution to skeletogenesis, at least during
early life (Figure 4) (Ding et al., 2012; Mizoguchi et al., 2014;
Zhou et al., 2014). In contrast, OCR stem cells are most active
during development, giving rise to trabecular bone, cartilage,
and reticular marrow stromal cells. Although it was reported
that all adult bone marrow CFU-Fs are Nes-GFP+ (Méndez-Ferrer et al., 2010), Grem1 OCR stem cells are negative for Nes-GFP
and yet are clonogenic (Figures 1D–1G). We believe that this
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Figure 6. Grem1 Expression Identifies iRSCs
(A) Protocol.
(B and C) Grem1-creERT;R26-mT/mG adult induction identifies rare, single cells at the junction of the crypt and villus in the small intestine (green = Grem1creERT+, red = Grem1-creERT-negative). Over 1 year, Grem1+ cells expand to renew the entire periepithelial mesenchymal sheath. By 6 months, they are

(legend continued on next page)
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Figure 7. A Model in which the OCR Stem Cell and the Perisinusoidal MSC Make a Complementary Contribution to Skeletal Development,
Adult Homeostasis, and Repair

discrepancy may arise from differences in our isolation and
culture of the bone marrow. Bone marrow Nes-GFP cells were
originally isolated by bone flush without reported collagenase
digestion (Méndez-Ferrer et al., 2010), which enhances the yield
of CFU-Fs (Morikawa et al., 2009). Enzymatic digestion
was essential for liberating Grem1+ cells from the bone and
bone marrow. There were also differences in our mesenchymal
sorting strategy. We classified CD45–CD31–Ter-119– triplenegative cells as bone marrow mesenchyme, as previously
reported (Park et al., 2012), whereas in the original Nes-GFP
MSC study, CD45– alone was used as the mesenchymal arbiter
(Méndez-Ferrer et al., 2010). This may have resulted in some
CD31+ endothelial cells being collected, and given that Nes-GFP

is expressed in bone marrow endothelium (Ono et al., 2014), it is
conceivable that the mesenchymal Nes-GFP population we
evaluated (CD45–CD31–Ter-119–Nes-GFP+) was different from
that evaluated previously (Méndez-Ferrer et al., 2010).
Developmentally, Nes-GFP+ and Lepr-cre+ perisinusoidal
MSCs and Grem1+ OCR stem cells could represent different
cells within a common lineage. Although this remains a possibility, we note that Grem1+ cells do not give rise to Nes-GFP cells,
even 10 months after tamoxifen induction. Similarly, P1 induction
of Nes-creERT, or constitutive lineage tracing of Lepr+ cells using
the Lepr-cre (Zhou et al., 2014), did not lead to significant genetic
recombination of trabecular bone or cartilage in early life. In
contrast, trabecular bone and cartilage are clearly derived from

immediately beneath the intestinal stem cells at the crypt base (B and C). Axes are provided to indicate the longitudinal and circumferential axes (x and y), and
‘‘CVA’’ to designate the crypt-villus, or radial, axis.
(D) The mesenchymal expansion was plotted relative to the adjacent epithelial position; 20 well-orientated crypt-villus columns were quantified per mouse. n = 3–
5 mice at each time point; Kruskal-Wallis analysis (p < 0.0001) and post-hoc pairwise Mann-Whitney tests, corrected for multiple comparisons, revealed
significant differences (****p % 0.0001, *p % 0.05).
(E) The sheath was comprised of a reticulated population of stellate cells with long processes that encircled the entire intestinal gland. This cell encapsulated the
very base of the intestinal crypt, similar to the position of the cell identified in (C).
(F) The Grem1+ population self-renewed and was multipotent, generating both Acta2 positive (yellow cell, white arrow) and negative fibroblastic lineages.
(G) Transmission electron microscopy: the Grem1 lineage (yellow arrows) is immediately beneath the epithelial cells.
(H) Tissue engineering: representative images from n = 8 small-intestinal organoid unit transplants. Small intestines were harvested from 3-week-old, tamoxifeninduced donor mice. In the donor intestines, prior to harvest, there were single Grem1+ cells (red) near the isthmus of the intestinal gland. After digestion of the
donor intestines into organoid units, rare Grem1+ mesenchymal cells (red) were found within individual organoid units (inset).
(I) Four weeks after transplantation, TESIs develop, with the periepithelial mesenchymal sheath recapitulated from the donor Grem1+ cells (red). E-cadherin
staining (green) was used to identify the epithelium.
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Grem1+ cells. Thus, based on our data, and those of others (Ding
et al., 2012; Mizoguchi et al., 2014; Zhou et al., 2014), we
conclude that there are at least two skeletogenic stem cells
contributing to postnatal bone (Figure 7). Remarkably, only
OCR stem cells appear to generate articular and growth-plate
cartilage during development, and the contribution of perisinusoidal MSCs is modest until later adulthood, at which point the
perisinusoidal MSCs are ultimately capable of generating fat,
bone, and cartilage, particularly following injury (Figure 7)
(Zhou et al., 2014). We propose that the OCR stem cell is vital
in skeletogenesis, whereas the traditional perisinusoidal MSCs
gradually increase their skeletal contribution over time. Traditional MSCs appear to partner with OCR stem cells to repair
bone in the event of fracture, but this may again depend on the
developmental stage at which the injury occurs (Figure 7).
In contrast to perisinusoidal MSCs, the Grem1 OCR stem cells
did not generate adipocytes in vivo or in vitro. Thus, although the
Grem1+ cell is multipotent (giving rise to osteoblasts, chondrocytes, and reticular marrow stromal cells) and a bone fide stem
cell, it is not the usual origin of adipocytes, at least under the
conditions examined. The relative ascendency of perisinusoidal
MSCs in later adulthood could potentially explain the increasing
adipogenesis evident in the bone marrow in later life.
Our selected marker, Grem1, is a BMP antagonist that is
especially important for skeletal patterning and contributes to
postnatal skeletal homeostasis (Bénazet et al., 2009; Canalis
et al., 2012; Khokha et al., 2003). BMP signaling in skeletogenesis expands primitive mesenchymal cells, laying the foundation
for subsequent endochondral ossification (Kronenberg, 2003).
Despite expression of the BMP antagonist Grem1, BMP
signaling was elevated in OCR stem cells compared to the
Grem1-negative mesenchymal cells. Increased BMP signaling
is consistent with the location of OCR stem cells, which is immediately adjacent to the BMP-producing growth plate, and our
microarray and qPCR data suggest that OCR stem cells also
produce Bmps that may act in an autocrine fashion (Kronenberg,
2003).
Researchers have harvested MSC-like cells from many
different adult organs (Crisan et al., 2008). In the small intestine,
single Grem1+ iRSCs immediately subjacent to the epithelium
at the junction between the small-intestinal crypt and villus
(the intestinal isthmus) undergo slow division, to ultimately
generate the entire periepithelial sheath of the crypt and villus,
forming a closely connected mesenchymal network. In adulthood, this process takes about one year, during which time
the Grem1 iRSCs give rise to both Acta2-positive myofibroblasts
and Acta2-negative periepithelial fibroblasts, thus establishing
their endogenous self-renewal and compartment-specific
multipotentiality.
The Grem1+ iRSC is a different cell from the Grem1+ OCR stem
cell, with discrete functions and distinct lineage potential,
namely periepithelial mesenchyme rather than bone and cartilage. Nevertheless, it shares with the Grem1 OCR stem cell a
stellate morphology, relative quiescence, and most importantly
the properties of endogenous self-renewal and mesenchymal
multipotentiality.
The stem cell responsible for developing bone and cartilage
in vivo, the OCR stem cell, appears to show great promise for
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skeletal tissue engineering, particularly for conditions such
as osteoarthritis, osteoporosis, and fracture. Grem1 OCR
stem cells could be harvested from a donor animal, expanded
in vitro, and transplanted, both directly and serially, into the femurs of fractured recipient animals, resulting in osteochondral
differentiation in the callus. Future studies will be needed to
compare the ability of Grem1+ cells to heal skeletal diseases
relative to those of other mesenchymal progenitor populations.
Our discovery of analogous iRSCs is also likely to be important
in intestinal replacement and repair and may inform mesenchymal hierarchy in other complicated connective tissues,
including the tumor microenvironment.
Taken together, our findings confirm the existence and relevance of bone, cartilage, and reticular stromal stem cells and
present a paradigm shift in understanding the diverse origins of
connective tissues in health, aging, and disease.
EXPERIMENTAL PROCEDURES
Mice
We used the following lines: Nes-GFP (Mignone et al., 2004), Nes-CreERT2
(Dranovsky et al., 2011), Grem1-LacZ (Khokha et al., 2003), Acta2-RFP
(Magness et al., 2004), R26-LSL-ZsGreen (Madisen et al., 2010), R26-LSLTdTomato (Madisen et al., 2010), R26-LSL-mT/mG (Muzumdar et al., 2007),
2.3ColGFP (Kalajzic et al., 2002), R26-LSL-Confetti (Snippert et al., 2010),
and R26-LSL-DTA (Voehringer et al., 2008) (Table S1B). The R26-LSLmT/mG was used in the intestine to better appreciate intestinal architecture,
but for the bone marrow, either the R26-LSL-ZsGreen or the R26-LSLTdTomato was used to enable the addition of a second reporter, such as
Nes-GFP, 2.3colGFP or Acta2-RFP. We generated the Grem1-CreERT transgenic by BAC recombineering (clone RP24-317C19), as previously described
(Sharan et al., 2009). The recombineering primers amplified the CreERT-pA-fNf
cassette with 60 bp homology arms upstream and downstream of the
Grem1 translational start site in exon 2 (Table S1A). We generated three
founder lines. Line 3 displayed the greatest recombination following adult
tamoxifen induction, and it was backcrossed six generations to C57BL/6J.
All experiments were performed according to the guidelines of the Institute
of Comparative Medicine at Columbia University.
Marrow Stromal Cell Isolation
Long bones of the arms and legs were harvested and gently disrupted using a
mortar and pestle, in PBS with 2% FBS and 1 mM EDTA. The bone and all of
the liberated bone marrow were collected and digested in 0.25% collagenase
type I (Worthington, Lakewood, NJ, USA, LS004196) in PBS with 20% FBS, for
cell culture or flow cytometry.
Clonal In Vitro Bone Marrow MSC Culture, Clonogenicity Assays,
and Differentiation
Marrow stromal cells were plated at clonal density and cultured for 14 days in
aMEM + 10% defined MSC FBS + 1% penicillin/streptomycin. The total number of colonies, defined as R50 cells, were stained with Giemsa. The number
of clones were reported as (CFU-Fs)/1,000 cells plated. For differentiation,
single recombined clones were isolated using cloning cylinders and then
expanded and split for differentiation using Invitrogen StemPro differentiation
products into adipocytes, chondrocytes, and osteoblasts. All in vitro differentiation reported in this study is clonal.
Fracture Studies
Adult Grem1-creERT;R26-LSL-TdTomato;2.3ColGFP mice were induced with
tamoxifen with a 1 week washout period before fracture. Unilateral femoral
osteotomy was internally fixed by an angiocatheter. Femurs were harvested
at 7 days. For the fracture transplantation, a single Grem1-derived clone
(after adult in vivo induction) was expanded in vitro and then 500 3 106 cells
were mixed with a HyStem-C(TM) Hydrogel Kit (Glycosan) and injected

around the fracture sites of the recipient wild-type mice. The fractured bones
were harvested at 7 days. Some of the fracture callus was recultured to recover
the donor Grem1+ cells. The fractures were imaged by X-ray and a Kodak
In Vivo Multispectral Imaging System FX (carestream Health) specific for
TdTomato fluorescence.
Tissue-Engineered Small Intestines
Organoid units were harvested from 3-week-old, P1 tamoxifen-induced
Grem1-creERT;R26-LSL-TdTomato donor mice and transplanted into 8
wild-type adult C57BL/6 mice. The procedure was otherwise performed as
previously described (Levin et al., 2013) with the TESIs harvested at 4 weeks
post-implantation for analysis.
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